The Australian organ allocation system relies on equity and maximising effectiveness, but these are sometimes difficult to reconcile
Donated kidneys are scarce and valuable, generously supplied by living donors or altruistically after death. Access to the Australian kidney transplant waiting list requires individuals with end-stage kidney disease to be eligible for Medicare and accepted by a transplant program through meeting the medium to long term life expectancy eligibility criteria from the Transplantation Society of Australia and New Zealand (TSANZ).1 There are state by state and transplant unit specific approaches to listing based on geography and population variability.2 The current overall Australian 5-year kidney transplant recipient survival rate is about 90%, with 5-year kidney survival at about 80%,3 as reported through the Australia and New Zealand Dialysis and Transplant Registry.4 There is, on average, a five- to ten-fold reduction in mortality for patients who have received a kidney transplant compared with those who remain on dialysis, explaining the continued demand for kidneys for transplantation.5
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Transplantation Society of Australia and New Zealand. Clinical guidelines for organ transplantation from deceased donors — version 1.1, May 2017. TSANZ; 2017. www.tsanz.com.au/organallocationguidelines/index.asp (viewed June 2018).
- 2. Australia and New Zealand Dialysis and Transplant Registry. 40th Report. Chapter 6: Australian transplant waiting list. Adelaide: ANZDATA; 2018. http://www.anzdata.org.au/anzdata/AnzdataReport/40thReport/c06_waiting-list_2016v1.0_20180504.pdf (viewed July 2018).
- 3. Australia and New Zealand Dialysis and Transplant Registry. 40th Report. Chapter 7: transplantation. Adelaide: ANZDATA; 2018. http://www.anzdata.org.au/anzdata/AnzdataReport/40thReport/c07_transplant_2016_v1.0_20180509.pdf (viewed Aug 2018).
- 4. McDonald SP. Australia and New Zealand Dialysis and Transplant Registry. Kidney Int Suppl (2011) 2015; 5: 39-44.
- 5. McDonald SP, Russ GR. Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991–2001. Nephrol Dial Transplant 2002; 17: 2212-2219.
- 6. Pilcher D, Gladkis L, Arcia B, et al. Estimating the number of organ donors in Australian hospitals — implications for monitoring organ donation practices. Transplantation 2015; 99: 2203-2209.
- 7. Organ and Tissue Authority. Australian Organ and Tissue Authority. Australian Donation and Transplantation Activity Report 2017. OTA; 2017. https://donatelife.gov.au/sites/default/files/2017%20Australian%20Donations%20and%20Transplantation%20Activity%20Report.pdf (viewed June 2018).
- 8. Australian and New Zealand Organ Donation Registry. ANZOD annual report 2018. Adelaide: Australia and New Zealand Dialysis and Transplant Registry; 2018. http://www.anzdata.org.au/anzod/ANZODReport/2018/Appendix_1_Aus_tables_2017.xlsx (viewed July 2018).
- 9. Australia and New Zealand Organ Donation Registry. 2002 report. http://www.anzdata.org.au/anzod/ANZODReport/2002/2002anzod.pdf (viewed Aug 2018).
- 10. Calisa V, Craig JC, Howard K, et al. Survival and quality of life impact of a risk-based allocation algorithm for deceased donor kidney transplantation. Transplantation 2018. doi: 10.1097/TP.0000000000002144. [Epub ahead of print].
- 11. Clayton PA, McDonald SP, Snyder JJ, et al. External validation of the estimated posttransplant survival score for allocation of deceased donor kidneys in the United States. Am J Transplant 2014; 14: 1922-1926.
No relevant disclosures.